Linking Labile Heme with Thrombosis

Area of Science:

• Hematology
• Pathophysiology
• Biochemistry

Background:

• Thrombosis is a leading global cause of mortality.
• Hemolytic diseases, such as sickle cell disease, often involve red blood cell lysis, releasing heme.
• Free heme in circulation can induce oxidative stress, inflammation, and potentially thrombosis.

Purpose of the Study:

• To review the current understanding of heme's role in activating blood coagulation.
• To explore the mechanisms by which heme contributes to thrombotic events in hemolytic conditions.
• To highlight the clinical relevance of heme in thrombosis treatment for hemolytic disorders.

Main Methods:

• Literature review of existing studies on heme and coagulation.
• Analysis of experimental data from heme infusion studies.
• Synthesis of findings on heme's direct effects on coagulation factors and cells.

Main Results:

• Heme release from lysed red blood cells is implicated in initiating thrombosis in hemolytic diseases.
• Heme can activate the blood coagulation cascade through various proposed mechanisms.
• Direct effects of heme on coagulation components are reported but remain debated and not fully elucidated.

Conclusions:

• Heme plays a significant, though complex, role in the pathogenesis of thrombosis associated with hemolytic disorders.
• Further research is needed to clarify the precise mechanisms of heme-coagulation interactions.
• Considering heme's prothrombotic potential is crucial for developing effective treatments for thrombosis in these patients.